Tarsus Pharmaceuticals (TARS) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.37
-1.21
-1.04
-0.88

Details

Expected EPS
-0.923022
Actual EPS
-0.88
Surprise EPS
0.04
Surprise Percent
+4.66%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.88 per share for Q3 2024.

0 Comments

Share your thoughts